• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

stevanato group

Stevanato Group, Owen Mumford to collaborate on Aidaptus auto-injector

May 4, 2022 By Sean Whooley

Stevanato Group (NYSE:STVN) announced today that it signed an exclusive agreement with Owen Mumford for its auto-injector technology. Piombino Dese, Italy-based Stevanato Group’s agreement makes it an exclusive manufacturing partner for Owen Mumford’s Aidaptus auto-injector. Under the agreement, Stevanato Group will mold the components for the technology and provide final and sub-assembly equipment, along with market-leading pre-filled syringes. […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations Tagged With: owenmumford, stevanato group

Stevanato Group, Bexson expand partnership for wearable drug delivery device

April 29, 2022 By Sean Whooley

Stevanato Group and Bexson Biomedical announced today that they agreed to expand their drug delivery collaboration. Under the agreement, Bexson has access to the use of a customized version of Stevanato’s SG EZ-be Pod wearable delivery system so it can develop new therapeutics for treating an array of mental health conditions, including treatment-resistant depression and post-traumatic stress disorder […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Neurological, Pain Management Tagged With: Bexson Biomedical, stevanato group

Stevanato Group acquires facility set to become manufacturing hub in China

March 10, 2022 By Sean Whooley

Stevanato Group (NYSE:STVN) announced today that it acquired a facility in Zhangjiagang, China, for a new manufacturing plant. Piombino Dese, Italy-based Stevanato Group expects to begin renovations on the facility in the spring of 2022 as it works to expand in China with a new manufacturing hub for drug containment, drug delivery and diagnostic development. Get […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Pharmaceutical Tagged With: stevanato group

Stevanato Group extends licensing agreement with Haselmeier for pen injector tech

January 26, 2022 By Sean Whooley

Stevanato Group (NYSE:STVN) announced today that it signed an extension to a licensing agreement with Haselmeier over its pen injector technology. Piombino Dese, Italy-based Stevanato Group’s license extension gives the company exclusivity to offer the Axis-D pen injector technology in support of a broader range of drugs for its biopharma customers beyond diabetes, including areas such […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Pharmaceutical Tagged With: haselmeier, stevanato group

FDA gives Bexson pre-IND guidance for ketamine formulation delivered by wearable pump

November 18, 2021 By Sean Whooley

Bexson Biomedical announced today that it received pre-investigational new drug guidance from the FDA for its ketamine compound therapy. Santa Barbara, California-based Bexson develops the patented BB106 formulation, a ketamine therapy delivered through a wearable, subcutaneous patch pump in development with Stevanato Group. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Neurological, Pain Management, Pharmaceutical Tagged With: Bexson Biomedical, FDA, stevanato group

Stevanato Group expands corporate headquarters

November 17, 2021 By Sean Whooley

Stevanato Group (NYSE:STVN) announced today that it expanded its corporate headquarters with a new facility in Italy. Based in Piombino Dese, Italy, Stevanato Group expects its 6,750-square-meter facility to support the optimization of its industrial footprint while advancing operations and growth within the company. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: stevanato group

Stevanato Group beats The Street in Q3, raises guidance

November 9, 2021 By Sean Whooley

Stevanato Group (NYSE:STVN) shares hit a snag today despite third-quarter results that beat the consensus forecast. The Piombino Dese, Italy-based drug delivery technology developer posted profits of $21.6 million, or 8¢ per share, on sales of $248.6 million for the three months ended Sept. 30, 2021, for a 12.5% bottom-line gain on sales growth of 36.5%. […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, MassDevice Earnings Roundup, Pharmaceutical, Wall Street Beat Tagged With: stevanato group

Stevanato Group is constructing a new facility in Indiana

October 4, 2021 By Sean Whooley

Stevanato Group (NYSE:STVN) announced today that it will begin construction on a new U.S. facility in Fishers, Indiana. Piombino Dese, Italy-based Stevanato Group will begin construction on the new facility this month with expectations for the site to be operational in 2023. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: stevanato group

MedTech 100 roundup: On the rise again

August 23, 2021 By Sean Whooley

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Alcon, Eli Lilly, Grail, Illumina Inc., Johnson & Johnson, MedTech 100 Index, Personnel Moves, Ra Medical, stevanato group, Strata Skin Sciences, Stryker, Ultrahuman

Stevanato Group brings in upsized IPO worth $453.5M

August 17, 2021 By Sean Whooley

Stevanato Group announced today that the underwriters of its recently completed initial public offering purchased more than 1 million additional shares. The option exercised by the underwriters saw the acquisition of an additional 1,018,280 ordinary Stevanato Group shares at $21 per share. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Funding Roundup, Initial Public Offering (IPO), Pharmaceutical, Wall Street Beat Tagged With: initial public offering, IPO, stevanato group

Haselmeier licenses Axis-D pen injector to Stevanato Group

October 7, 2019 By Sean Whooley

Haselmeier said today that it entered into an exclusive agreement with Stevanato Group to license the Axis-D pen injector and intellectual property for the development, manufacturing and supply of the device for diabetes care. Haselmeier’s Axis-D auto-injector pen is approved for use by the European Medical Agency and the FDA, among other regulatory bodies. The […]

Filed Under: Business/Financial News, Diabetes, Mergers & Acquisitions Tagged With: haselmeier, stevanato group

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS